- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Bimekizumab
Total 97 results
-
Second Affiliated Hospital, School of Medicine,...Not yet recruiting
-
Eli Lilly and CompanyCompleted
-
Eli Lilly and CompanyCompletedAxial SpondyloarthritisUnited States, Puerto Rico, Russian Federation, Mexico, Poland, Argentina, Austria, Brazil, Canada, Czechia, Finland, Germany, Japan, Korea, Republic of, Netherlands, Romania
-
Eli Lilly and CompanyCompletedGeneralized Pustular Psoriasis | Erythrodermic PsoriasisJapan
-
Eli Lilly and CompanyCompletedPsoriasis | Genital PsoriasisTurkey, Puerto Rico, United States, Australia, Belgium, Austria, Netherlands, Canada
-
UCB CelltechPRA Health SciencesCompletedMultiple Dose Study of UCB4940 as add-on to Certolizumab Pegol in Subjects With Rheumatoid ArthritisRheumatoid ArthritisCzechia, Hungary, Moldova, Republic of, Poland, Russian Federation, Slovakia, United Kingdom
-
UCB Biopharma SRLCompletedPsoriatic Arthritis | Moderate to Severe Chronic Plaque Psoriasis | Chronic Plaque PsoriasisUnited States, Australia, Belgium, Canada, Germany, Hungary, Italy, Japan, Poland, Russian Federation, United Kingdom
-
Ohio State UniversityEli Lilly and CompanyCompletedPyoderma GangrenosumUnited States
-
Eli Lilly and CompanyCompleted
-
Eli Lilly and CompanyCompleted
-
University Hospital, GhentBelgium Health Care Knowledge CentreNot yet recruiting
-
Eli Lilly and CompanyCompletedAxial SpondyloarthritisUnited States, Puerto Rico, Korea, Republic of, Netherlands, Taiwan, Canada, Israel, Spain, Japan, Brazil, Argentina, Hungary, Poland, Czechia, France, Russian Federation, Germany, Mexico, United Kingdom, Romania, Italy, Finland, Au...
-
Oregon Health and Science UniversityEli Lilly and CompanyCompletedPityriasis Rubra PilarisUnited States
-
Eli Lilly and CompanyCompletedPsoriatic ArthritisSpain, Bulgaria, Czechia, Estonia, Mexico, Poland, Ukraine, United States, South Africa, Russian Federation, Slovakia, United Kingdom
-
Eli Lilly and CompanyCompletedSpondyloarthritisItaly, Japan, United States, Puerto Rico, Spain, Mexico, Netherlands, France, Poland, Israel, Argentina, Brazil, Canada, Korea, Republic of, Germany, Finland, United Kingdom
-
Eli Lilly and CompanyCompletedA Study of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque Psoriasis (IXORA-S)Plaque PsoriasisGermany, Spain, Belgium, France, Hungary, Austria, Canada, Italy, Netherlands, Poland, Sweden, Switzerland, United Kingdom
-
Göteborg UniversityGothia Forum - Center for Clinical Trial; Statistiska KonsultgruppenRecruiting
-
UCB Biopharma SRLCompletedModerate to Severe Plaque Psoriasis | Chronic Plaque PsoriasisUnited States, Australia, Canada, Germany, Hungary, Korea, Republic of, Poland, Russian Federation, Taiwan
-
Eli Lilly and CompanyCompletedPlaque PsoriasisUnited States, Puerto Rico, Canada
-
Eli Lilly and CompanyCompletedPsoriatic ArthritisBelgium, Hungary, Canada, India, Israel, Italy, Australia, Netherlands, United Kingdom, Mexico, Switzerland, South Africa, Poland, Finland, Argentina, France, Germany, Ukraine, Spain, Austria, Denmark, Sweden
-
Eli Lilly and CompanyCompleted
-
Eli Lilly and CompanyWithdrawnSpondylitis, AnkylosingSpain, United States, Hungary, Belgium, France, Mexico, Netherlands, Poland, Russian Federation, Ukraine, United Kingdom, Canada, Argentina, Germany, Czech Republic
-
Eli Lilly and CompanyCompletedSpondyloarthritisTaiwan, United States, Korea, Republic of, Germany, Czechia, Japan, Netherlands
-
Assiut UniversityNot yet recruitingSpontaneous Bacterial Peritonitis
-
Eli Lilly and CompanyCompletedPlaque PsoriasisArgentina, Puerto Rico, United States, Australia, Taiwan, Japan, Hungary, Korea, Republic of, Mexico, Germany, Poland, Romania, Czechia, Canada
-
UCB Biopharma SRLCompletedPsoriatic ArthritisUnited States, Australia, Belgium, Canada, Czechia, France, Germany, Hungary, Italy, Japan, Poland, Russian Federation, Spain, United Kingdom
-
Xcovery Holding Company, LLCCompletedAdvanced Solid Tumors | Non-small Cell Lung CancerUnited States
-
Eli Lilly and CompanyCompletedPsoriasisUnited States, Hungary, Germany, Canada, Mexico, Bulgaria, Russian Federation, Poland, Argentina, Chile
-
Eli Lilly and CompanyCompletedPsoriasisUnited States, Germany, Spain, France, Austria, Canada, Poland, Australia, United Kingdom, Romania, Netherlands, Czechia
-
Eli Lilly and CompanyActive, not recruitingJuvenile Psoriatic Arthritis | Enthesitis Related ArthritisSpain, Belgium, Germany, Italy, United Kingdom, Denmark, Mexico, Netherlands, Switzerland
-
Eli Lilly and CompanyCompletedPsoriasis, ArthriticUnited States, Spain, Russian Federation, Belgium, Bulgaria, Canada, Czechia, Estonia, France, Japan, Mexico, Netherlands, Poland, Ukraine, United Kingdom
-
UCB Biopharma SRLCompletedAnkylosing SpondylitisUnited States, Czechia, Germany, Greece, Moldova, Republic of, Netherlands, Poland, Russian Federation
-
Eli Lilly and CompanyCompletedDyslipidemiaUnited States, Netherlands, Germany, Denmark, Poland, United Kingdom
-
Second Affiliated Hospital, School of Medicine,...RecruitingPsoriasis | ImmunoclassificationChina
-
Eli Lilly and CompanyCompleted
-
Kanuni Sultan Suleyman Training and Research HospitalCompleted
-
Eli Lilly and CompanyCompletedPlaque PsoriasisUnited States, Spain, Puerto Rico, Czechia, Canada, Germany, France, Poland, Hungary, Mexico, Russian Federation, Argentina, Netherlands
-
Seoul National University HospitalRecruitingRheumatoid Arthritis | Psoriatic Arthritis | Ankylosing SpondylitisKorea, Republic of
-
Prof. Dr. Stephan WeidingerRecruiting
-
University of Sao PauloConselho Nacional de Desenvolvimento Científico e Tecnológico; Science Valley...Completed
-
Eli Lilly and CompanyCompleted
-
Singapore General HospitalTranslational Immunology InstituteRecruitingPlaque PsoriasisSingapore
-
Boehringer IngelheimCompleted
-
Jeffrey CurtisBristol-Myers Squibb; Eli Lilly and Company; University of Pennsylvania; Novartis; Pfiz... and other collaboratorsRecruitingRheumatoid Arthritis | Spondylarthritis | Psoriatic ArthritisUnited States
-
Eli Lilly and CompanyCompleted
-
University of Erlangen-Nürnberg Medical SchoolRecruitingPsoriatic Arthritis | Withdrawal | ReductionGermany